Cyclin E and CDK2 are important regulators of the G1/S checkpoint during cell cycle progression and our data above showed that PD173074 treatment led to a marked increase in G1-accumulated HCC cells (Fig 1D and 1E). Here, CDK2 is linked to hepatocellular carcinoma.